Cardiac Lymphatics - A New Avenue for Therapeutics?

Taina Vuorio1, Annakaisa Tirronen1, Seppo Ylä-Herttuala2

  • 1Department of Biotechnology and Molecular Medicine, A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, PO Box 1627, 70211 Kuopio, Finland.

Insights

The lymphatic vasculature is crucial for cardiovascular health, regulating fluid balance and immune cell transport. Therapies targeting lymphatic vessels show promise for treating heart diseases like atherosclerosis and myocardial infarction.

Area of Science:

  • Cardiovascular Biology
  • Lymphatic System Research
  • Medical Imaging

Background:

  • The lymphatic vasculature plays a vital role in maintaining cardiovascular homeostasis.
  • It regulates fluid balance, protein transport, and immune cell trafficking, impacting heart function.
  • Recent advancements in imaging have highlighted the significance of lymphatic vessels.

Purpose of the Study:

  • To review recent findings on cardiac lymphatic vessel development and function.
  • To explore the therapeutic potential of lymphangiogenic therapies in cardiovascular diseases.
  • To discuss prospects for pro- and anti-lymphangiogenic treatments.

Main Methods:

  • Literature review of recent studies on lymphatic vessel biology.
  • Analysis of novel imaging techniques in cardiovascular research.
  • Synthesis of current knowledge on cardiac lymphatic system and disease.

Main Results:

  • Lymphatic vessels are integral to the cardiovascular system, influencing key physiological processes.
  • Therapeutic strategies targeting lymphatic vessels may offer new treatments for cardiovascular conditions.
  • Potential applications include improving reverse cholesterol transport and resolving post-myocardial infarction complications.

Conclusions:

  • Understanding cardiac lymphatic vessel biology is essential for cardiovascular health.
  • Lymphangiogenic therapies present a promising avenue for treating cardiovascular diseases.
  • Further research into manipulating lymphatic function could revolutionize cardiovascular medicine.

Related Concept Videos

Lymphatic Vessels and Lymph Transport01:16

Lymphatic Vessels and Lymph Transport

Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular...
24.1K
Development of the Lymphatic System01:15

Development of the Lymphatic System

The development of lymphatic tissues and vessels in embryonic life begins around the fifth week. These structures originate from the mesoderm layer, with lymph sacs emerging from developing veins.
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
2.4K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
564
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689